Adaptive Biotechnologies
ADPT
#3289
Rank
S$5.86 B
Marketcap
S$36.22
Share price
-1.44%
Change (1 day)
102.50%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: S$5.86 Billion

As of November 2026 Adaptive Biotechnologies has a market cap of S$5.86 Billion. This makes Adaptive Biotechnologies the world's 3289th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026S$5.86 B82.88%
2025S$3.20 B166.27%
2024S$1.20 B28.53%
2023S$0.93 B-36.04%
2022S$1.46 B-72.64%
2021S$5.35 B-49.96%
2020S$10.69 B111.79%
2019S$5.05 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Adaptive Biotechnologies was reported to be:

S$5.94 Billion
by Nasdaq info icon info icon
S$5.94 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
S$124.18 B 2,017.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
S$3.01 B-48.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
S$0.29 B-95.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
S$2.64 B-54.93%๐Ÿ‡บ๐Ÿ‡ธ USA